table of content
1 Pediatric Drugs and Vaccines Market Overview
1.1 Product Overview and Scope of Pediatric Drugs and Vaccines
1.2 Pediatric Drugs and Vaccines Segment by Type
1.2.1 Global Pediatric Drugs and Vaccines Sales Growth Rate Comparison by Type (2023-2032)
1.2.2 Diphtheria
1.2.3 Influenza
1.2.4 Hepatitis
1.2.5 Pneumococcal Diseases
1.2.6 Meningococcal Diseases
1.2.7 Mumps
1.2.8 Others
1.3 Pediatric Drugs and Vaccines Segment by Application
1.3.1 Global Pediatric Drugs and Vaccines Sales Comparison by Application: (2023-2032)
1.3.2 Newborn
1.3.3 Infant
1.3.4 Child
1.4 Global Pediatric Drugs and Vaccines Market Size Estimates and Forecasts
1.4.1 Global Pediatric Drugs and Vaccines Revenue 2018-2032
1.4.2 Global Pediatric Drugs and Vaccines Sales 2018-2032
1.4.3 Pediatric Drugs and Vaccines Market Size by Region: 2018 Versus 2022 Versus 2032
2 Pediatric Drugs and Vaccines Market Competition by Manufacturers
2.1 Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pediatric Drugs and Vaccines Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Pediatric Drugs and Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Pediatric Drugs and Vaccines Market Competitive Situation and Trends
2.5.1 Pediatric Drugs and Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pediatric Drugs and Vaccines Players Market Share by Revenue
2.5.3 Global Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pediatric Drugs and Vaccines Retrospective Market Scenario by Region
3.1 Global Pediatric Drugs and Vaccines Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Pediatric Drugs and Vaccines Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Pediatric Drugs and Vaccines Market Facts & Figures by Country
3.3.1 North America Pediatric Drugs and Vaccines Sales by Country
3.3.2 North America Pediatric Drugs and Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pediatric Drugs and Vaccines Market Facts & Figures by Country
3.4.1 Europe Pediatric Drugs and Vaccines Sales by Country
3.4.2 Europe Pediatric Drugs and Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pediatric Drugs and Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Region
3.5.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pediatric Drugs and Vaccines Market Facts & Figures by Country
3.6.1 Latin America Pediatric Drugs and Vaccines Sales by Country
3.6.2 Latin America Pediatric Drugs and Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pediatric Drugs and Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Country
3.7.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Pediatric Drugs and Vaccines Historic Market Analysis by Type
4.1 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2018-2023)
4.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2018-2023)
4.3 Global Pediatric Drugs and Vaccines Price by Type (2018-2023)
5 Global Pediatric Drugs and Vaccines Historic Market Analysis by Application
5.1 Global Pediatric Drugs and Vaccines Sales Market Share by Application (2018-2023)
5.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2018-2023)
5.3 Global Pediatric Drugs and Vaccines Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Merck & Co., Inc. (USA)
6.1.1 Merck & Co., Inc. (USA) Corporation Information
6.1.2 Merck & Co., Inc. (USA) Description and Business Overview
6.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.1.5 Merck & Co., Inc. (USA) Recent Developments/Updates
6.2 Abbott Laboratories (USA)
6.2.1 Abbott Laboratories (USA) Corporation Information
6.2.2 Abbott Laboratories (USA) Description and Business Overview
6.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Portfolio
6.2.5 Abbott Laboratories (USA) Recent Developments/Updates
6.3 Amgen, Inc. (USA)
6.3.1 Amgen, Inc. (USA) Corporation Information
6.3.2 Amgen, Inc. (USA) Description and Business Overview
6.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.3.5 Amgen, Inc. (USA) Recent Developments/Updates
6.4 Eli Lilly and Company (USA)
6.4.1 Eli Lilly and Company (USA) Corporation Information
6.4.2 Eli Lilly and Company (USA) Description and Business Overview
6.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Portfolio
6.4.5 Eli Lilly and Company (USA) Recent Developments/Updates
6.5 F. Hoffmann-La Roche Ltd (Switzerland)
6.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
6.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Description and Business Overview
6.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Portfolio
6.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments/Updates
6.6 Genentech, Inc. (USA)
6.6.1 Genentech, Inc. (USA) Corporation Information
6.6.2 Genentech, Inc. (USA) Description and Business Overview
6.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.6.5 Genentech, Inc. (USA) Recent Developments/Updates
6.7 GlaxoSmithKline plc. (UK)
6.6.1 GlaxoSmithKline plc. (UK) Corporation Information
6.6.2 GlaxoSmithKline plc. (UK) Description and Business Overview
6.6.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Portfolio
6.7.5 GlaxoSmithKline plc. (UK) Recent Developments/Updates
6.8 Janssen Biologics B.V. (USA)
6.8.1 Janssen Biologics B.V. (USA) Corporation Information
6.8.2 Janssen Biologics B.V. (USA) Description and Business Overview
6.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.8.5 Janssen Biologics B.V. (USA) Recent Developments/Updates
6.9 Actelion Pharmaceuticals
6.9.1 Actelion Pharmaceuticals Corporation Information
6.9.2 Actelion Pharmaceuticals Description and Business Overview
6.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Portfolio
6.9.5 Actelion Pharmaceuticals Recent Developments/Updates
6.10 AstraZeneca Plc. (UK)
6.10.1 AstraZeneca Plc. (UK) Corporation Information
6.10.2 AstraZeneca Plc. (UK) Description and Business Overview
6.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Portfolio
6.10.5 AstraZeneca Plc. (UK) Recent Developments/Updates
6.11 Boehringer Ingelheim GmbH (Germany)
6.11.1 Boehringer Ingelheim GmbH (Germany) Corporation Information
6.11.2 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Description and Business Overview
6.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Portfolio
6.11.5 Boehringer Ingelheim GmbH (Germany) Recent Developments/Updates
6.12 Bristol-Myers Squibb Company (USA)
6.12.1 Bristol-Myers Squibb Company (USA) Corporation Information
6.12.2 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Description and Business Overview
6.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Portfolio
6.12.5 Bristol-Myers Squibb Company (USA) Recent Developments/Updates
6.13 Allergan, Inc. (USA)
6.13.1 Allergan, Inc. (USA) Corporation Information
6.13.2 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Description and Business Overview
6.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.13.5 Allergan, Inc. (USA) Recent Developments/Updates
6.14 Novartis AG (Switzerland)
6.14.1 Novartis AG (Switzerland) Corporation Information
6.14.2 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Description and Business Overview
6.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Portfolio
6.14.5 Novartis AG (Switzerland) Recent Developments/Updates
6.15 Novo Nordisk A/S (Denmark)
6.15.1 Novo Nordisk A/S (Denmark) Corporation Information
6.15.2 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Description and Business Overview
6.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Portfolio
6.15.5 Novo Nordisk A/S (Denmark) Recent Developments/Updates
6.16 Pfizer, Inc. (USA)
6.16.1 Pfizer, Inc. (USA) Corporation Information
6.16.2 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Description and Business Overview
6.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.16.5 Pfizer, Inc. (USA) Recent Developments/Updates
6.17 Sanofi S.A (France)
6.17.1 Sanofi S.A (France) Corporation Information
6.17.2 Sanofi S.A (France) Pediatric Drugs and Vaccines Description and Business Overview
6.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Portfolio
6.17.5 Sanofi S.A (France) Recent Developments/Updates
6.18 Shionogi Inc. (USA)
6.18.1 Shionogi Inc. (USA) Corporation Information
6.18.2 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Description and Business Overview
6.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.18.5 Shionogi Inc. (USA) Recent Developments/Updates
6.19 Takeda
6.19.1 Takeda Corporation Information
6.19.2 Takeda Pediatric Drugs and Vaccines Description and Business Overview
6.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Takeda Pediatric Drugs and Vaccines Product Portfolio
6.19.5 Takeda Recent Developments/Updates
7 Pediatric Drugs and Vaccines Manufacturing Cost Analysis
7.1 Pediatric Drugs and Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pediatric Drugs and Vaccines
7.4 Pediatric Drugs and Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pediatric Drugs and Vaccines Distributors List
8.3 Pediatric Drugs and Vaccines Customers
9 Pediatric Drugs and Vaccines Market Dynamics
9.1 Pediatric Drugs and Vaccines Industry Trends
9.2 Pediatric Drugs and Vaccines Market Drivers
9.3 Pediatric Drugs and Vaccines Market Challenges
9.4 Pediatric Drugs and Vaccines Market Restraints
10 Global Market Forecast
10.1 Pediatric Drugs and Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pediatric Drugs and Vaccines by Type (2023-2032)
10.1.2 Global Forecasted Revenue of Pediatric Drugs and Vaccines by Type (2023-2032)
10.2 Pediatric Drugs and Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pediatric Drugs and Vaccines by Application (2023-2032)
10.2.2 Global Forecasted Revenue of Pediatric Drugs and Vaccines by Application (2023-2032)
10.3 Pediatric Drugs and Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pediatric Drugs and Vaccines by Region (2023-2032)
10.3.2 Global Forecasted Revenue of Pediatric Drugs and Vaccines by Region (2023-2032)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
